title: Risks inherent in fetal gene therapy.
authors.forename: D
authors.initials: D
authors.lastname: King
authors.forename: T
authors.initials: T
authors.lastname: Shakespeare
authors.forename: R
authors.initials: R
authors.lastname: Nicholson
authors.forename: A
authors.initials: A
authors.lastname: Clarke
authors.forename: S
authors.initials: S
authors.lastname: McLean
mesh_terms: D005053:Eugenics; D005315:Fetal Diseases / Q000628:therapy*; D033042:Fetal Research; D005818:Genetic Engineering / Q000331:legislation & jurisprudence; D024861:Genetic Enhancement; D015316:Genetic Therapy / Q000331:legislation & jurisprudence; D005854:Germ Cells; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors; D016511:Severe Combined Immunodeficiency / Q000628:therapy; D006113:United Kingdom; D014481:United States